Logo image of VMX.PA

VERIMATRIX SA (VMX.PA) Stock Fundamental Analysis

EPA:VMX - FR0010291245 - Common Stock

0.2 EUR
0 (-1.48%)
Last: 9/2/2025, 10:09:46 AM
Fundamental Rating

1

VMX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 108 industry peers in the Software industry. VMX may be in some trouble as it scores bad on both profitability and health. VMX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

VMX had negative earnings in the past year.
VMX had a positive operating cash flow in the past year.
VMX had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: VMX reported negative operating cash flow in multiple years.
VMX.PA Yearly Net Income VS EBIT VS OCF VS FCFVMX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

With a Return On Assets value of -67.57%, VMX is not doing good in the industry: 87.96% of the companies in the same industry are doing better.
With a Return On Equity value of -149.99%, VMX is not doing good in the industry: 84.26% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -67.57%
ROE -149.99%
ROIC N/A
ROA(3y)-7.28%
ROA(5y)-4.86%
ROE(3y)-11.32%
ROE(5y)-7.72%
ROIC(3y)N/A
ROIC(5y)N/A
VMX.PA Yearly ROA, ROE, ROICVMX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

VMX has a Gross Margin (66.57%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of VMX has declined.
The Profit Margin and Operating Margin are not available for VMX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.53%
GM growth 5Y-3.2%
VMX.PA Yearly Profit, Operating, Gross MarginsVMX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

VMX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VMX has about the same amount of shares outstanding.
The number of shares outstanding for VMX has been increased compared to 5 years ago.
Compared to 1 year ago, VMX has an improved debt to assets ratio.
VMX.PA Yearly Shares OutstandingVMX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
VMX.PA Yearly Total Debt VS Total AssetsVMX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

VMX has an Altman-Z score of -0.67. This is a bad value and indicates that VMX is not financially healthy and even has some risk of bankruptcy.
VMX's Altman-Z score of -0.67 is on the low side compared to the rest of the industry. VMX is outperformed by 82.41% of its industry peers.
VMX has a debt to FCF ratio of 36.72. This is a negative value and a sign of low solvency as VMX would need 36.72 years to pay back of all of its debts.
VMX has a Debt to FCF ratio (36.72) which is in line with its industry peers.
VMX has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
VMX's Debt to Equity ratio of 0.28 is in line compared to the rest of the industry. VMX outperforms 54.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 36.72
Altman-Z -0.67
ROIC/WACCN/A
WACC7.26%
VMX.PA Yearly LT Debt VS Equity VS FCFVMX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.83 indicates that VMX may have some problems paying its short term obligations.
VMX's Current ratio of 0.83 is on the low side compared to the rest of the industry. VMX is outperformed by 73.15% of its industry peers.
VMX has a Quick Ratio of 0.83. This is a bad value and indicates that VMX is not financially healthy enough and could expect problems in meeting its short term obligations.
VMX has a Quick ratio of 0.82. This is in the lower half of the industry: VMX underperforms 73.15% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.82
VMX.PA Yearly Current Assets VS Current LiabilitesVMX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for VMX have decreased strongly by -538.46% in the last year.
The Revenue for VMX has decreased by -14.46% in the past year. This is quite bad
Measured over the past years, VMX shows a very negative growth in Revenue. The Revenue has been decreasing by -10.24% on average per year.
EPS 1Y (TTM)-538.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1420%
Revenue 1Y (TTM)-14.46%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.24%
Sales Q2Q%-13.99%

3.2 Future

VMX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.87% yearly.
VMX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.01% yearly.
EPS Next Y-700%
EPS Next 2Y7.24%
EPS Next 3Y11.87%
EPS Next 5YN/A
Revenue Next Year-15%
Revenue Next 2Y-6.06%
Revenue Next 3Y-2.01%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VMX.PA Yearly Revenue VS EstimatesVMX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
VMX.PA Yearly EPS VS EstimatesVMX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

VMX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VMX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VMX.PA Price Earnings VS Forward Price EarningsVMX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VMX is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, VMX is valued a bit cheaper than 74.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.84
EV/EBITDA 22.27
VMX.PA Per share dataVMX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.24%
EPS Next 3Y11.87%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VMX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERIMATRIX SA

EPA:VMX (9/2/2025, 10:09:46 AM)

0.2

0 (-1.48%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-28 2025-07-28
Earnings (Next)10-22 2025-10-22
Inst Owners5.44%
Inst Owner ChangeN/A
Ins Owners2.39%
Ins Owner ChangeN/A
Market Cap17.47M
Analysts47.5
Price Target0.27 (35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-21.21%
PT rev (3m)-21.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-884.13%
EPS NY rev (3m)-884.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.68%
Revenue NY rev (3m)-3.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF 22.84
P/OCF 6.65
P/B 0.43
P/tB N/A
EV/EBITDA 22.27
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.01
FCFY4.38%
OCF(TTM)0.03
OCFY15.03%
SpS0.52
BVpS0.46
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67.57%
ROE -149.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.57%
FCFM 1.69%
ROA(3y)-7.28%
ROA(5y)-4.86%
ROE(3y)-11.32%
ROE(5y)-7.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.53%
GM growth 5Y-3.2%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 36.72
Debt/EBITDA 6.12
Cap/Depr 36.28%
Cap/Sales 4.12%
Interest Coverage N/A
Cash Conversion 141.62%
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.82
Altman-Z -0.67
F-Score4
WACC7.26%
ROIC/WACCN/A
Cap/Depr(3y)35.24%
Cap/Depr(5y)53.33%
Cap/Sales(3y)4.63%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-538.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1420%
EPS Next Y-700%
EPS Next 2Y7.24%
EPS Next 3Y11.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.46%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.24%
Sales Q2Q%-13.99%
Revenue Next Year-15%
Revenue Next 2Y-6.06%
Revenue Next 3Y-2.01%
Revenue Next 5YN/A
EBIT growth 1Y16.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year250.88%
EBIT Next 3Y63.47%
EBIT Next 5YN/A
FCF growth 1Y-83.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.89%
OCF growth 3YN/A
OCF growth 5YN/A